Roche

company on 10 shows · 8 statements across 5 episodes · said 29 times in 17 episodes since 2018

the a16z Podcast 8 the Neon Show 4 All-In 4 Top Founders 3 20VC 3 Capital Allocators 2 TBPN 2 Acquired 1 the Startup Ideas Podcast 1 How I Built This 1

Mentions by year, every show

tap a year for its mentions
004284201820192020202120222023202420252026episodesmentions
024201820192020202120222023202420252026episodes it came up in
002244201820192020202120222023202420252026episodesmentions per episode

the a16z Podcast 8All-In 4the Neon Show 4Top Founders 320VC 3Capital Allocators 2TBPN 2How I Built This 12 more shows

2026 1 mention in 1 episode
2025 4 mentions in 2 episodes 2 per episode
2024 4 mentions in 4 episodes 1 per episode
2023 3 mentions in 1 episode
2022 7 mentions in 3 episodes 2 per episode
2021 2 mentions in 2 episodes 1 per episode
2020 2 mentions in 2 episodes 1 per episode
2019 4 mentions in 1 episode
2018 2 mentions in 1 episode

every mention on every show, scene by scene, with the transcript →

8 statements about Roche, every show

ALL-IN Assertion Supported
Chamath: Flatiron Health's $1.9B Roche acquisition remains health ML's largest exit
“I was a early investor, Series A investor in a company called Flatiron Health. We sold it for 1.9 billion dollars to Roche. That's the biggest exit in this space for this machine learning enabled stuff. It happened in 2018.”
Chamath Palihapitiya Jan 20, 2023 ▶ 1:25:54 E112: Is Davos a grift? Plus: globalist mishaps, debt ceilings, TikTok's endgame & more
NEON SHOW Assertion Not checkable as stated
Anand: Roche accounted for $2M of ValueEdge's $6.5M–$7M revenue
“In the short journey of Value Edge of seven, eight years, Roche became a two million dollar business. And in, in a company which eventually had a business size of around six and a half, seven million dollars.”
Rohit Anand Mar 21, 2022 ▶ 13:58 How He Sold His BOOTSTRAPPED BUSINESS For $20 MILLION! ft. Founder of 1DigitalStack, Rohit Anand
NEON SHOW Assertion Not checkable as stated
Anand: ValueEdge reached 150 employees and multiple $1M+ clients bootstrapped
“At the time of exit you know, we had a couple of million-dollar-plus clients. There was Roche, there was Merck, there was Bayer you know, blue-chip clients. And it was about a 150 people team with offices in the US in Europe, in Frankfurt and in Switzerland. S…”
Rohit Anand Mar 21, 2022 ▶ 15:24 How He Sold His BOOTSTRAPPED BUSINESS For $20 MILLION! ft. Founder of 1DigitalStack, Rohit Anand
TOP FOUNDERS Assertion Not checkable as stated
Mitchell: Roche Healthcare organically adopted Yac after its Product Hunt launch
“And a lot of them were in, like, weird industries we didn't expect either, like Roche Healthcare, like kind of an enterprise healthcare company, not a fun, you know, remote-first startup. So yeah, they just found out about it through Product Hunt, downloaded t…”
Justin Mitchell Feb 11, 2021 ▶ 7:02 Yac Is Audio Slack, Hits 10k Weekly Users, Raising $8m on $30m
20VC Assertion Supported
Roche acquired Flatiron Health for $2 billion
“Flatiron Health, acquired by Roche for two billion dollars”
Harry Stebbings Nov 6, 2020 ▶ 0:26 20VC: Zach Weinberg on Whether A Company is a Democracy, The Importance of Ownership, The Rise of Pre-Emptive Rounds, Multi-Stage Funds Entering Seed and How he Approaches Both Risk and Personal Capital Allocation
a16z Assertion Partly supported
Hirasaki: Major biopharma companies faced critical patent cliffs in 2018
“Roche lost exclusivity on Zolaire and Rituxin. Pfizer lost exclusivity on Lyrica. And GSK lost exclusivity on Advair.”
Koki Hirasaki Feb 28, 2019 ▶ 1:30 What’s with All the Bio M&A in 2019?: A Quick Take
a16z Assertion Supported
Hirasaki: Spark acquisition vaulted Roche forward in gene therapy platform technology
“And then with the Spark acquisition same thing BMS, I'm sorry Roche was a laggard in the space, and now suddenly leaped ahead with not only a marketed gene therapy, but this AAV platform that it could use for delivering other gene therapies.”
Koki Hirasaki Feb 28, 2019 ▶ 5:59 What’s with All the Bio M&A in 2019?: A Quick Take
a16z Assertion Supported
Hirasaki: Roche Allows Acquired Companies Like Spark to Operate Semi-Autonomously
“Some big pharma companies will just tend to fully integrate the company whereas others will like Roche and Spark will allow the acquired companies to operate semi-autonomously.”
Koki Hirasaki Feb 28, 2019 ▶ 16:10 What’s with All the Bio M&A in 2019?: A Quick Take

← every entity, every show

Made with StarZero

Turn any episode into a week of clips.

This entire site, thousands of episodes across every show transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.